A Novel Treatment for COVID 19: Gohibic

Bruce P. Burnett, PhD, VP Head of Medical Affairs, InflaRx Pharmaceuticals, Inc.

Thank you to InflaRx Pharmaceuticals, Inc.

Wednesday, April 23, 2025 5:30-8:30 at Noto's Italian Restaurant

Come and join us for this evening dinner presentation that will inform us about a new FDA Emergency Use Authorized medication for treatment of COVID-19 in hospitalized adults when initiated within 48 hours of receiving invasive mechanical ventilation.   This program will describe the supportive data from the PANAMO Phase III data surrounding the use of Gohibic (vilobelimab).  Join us for an evening of cutting-edge learning!! 

This event will award 1 CERP Category A.

Early Registration for AACN-WM Chapter Members open now.

General Registration opens March 26, 2025

Registration Deadline: April 18, 2025 @ 5pm

In lieu of registration fee, we will accept Kid's Food Basket Donations at the door.  Please bring an item from the Wish List:

• Dried Fruit
• Fruit Cups or Pouches
• Toasted Oat Cereal
• Cheese Crackers
• Pretzels
• Snack size zipper bags